Greylin Investment Mangement Inc Pfizer Inc Transaction History

Greylin Investment Mangement Inc

$566 Million
Q2 2024

A detailed history of Greylin Investment Mangement Inc transactions in Pfizer Inc stock. As of the latest transaction made, Greylin Investment Mangement Inc holds 338,910 shares of PFE stock, worth $9.06 Million. This represents 1.68% of its overall portfolio holdings.

Number of Shares

338,910

Previous 249,672 35.74%

Holding current value

$9.06 Million

Previous $6.93 Million 36.86%

% of portfolio

1.68%

Previous 1.17%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	BUY	$25.26 - $29.6 $2.25 Million - $2.64 Million	89,238 Added 35.74%	338,910 $9.48 Million
Q1 2024 Apr 24, 2024	BUY	$25.89 - $29.73 $1.97 Million - $2.26 Million	76,137 Added 43.87%	249,672 $6.93 Million
Q4 2023 Jan 25, 2024	BUY	$26.13 - $33.94 $4.06 Million - $5.27 Million	155,355 Added 854.54%	173,535 $5 Million
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $53,044 - $62,004	-1,653 Reduced 8.33%	18,180 $603,000
Q2 2023 Jul 10, 2023	SELL	$36.12 - $41.79 $94,995 - $109,907	-2,630 Reduced 11.71%	19,833 $727,000
Q1 2023 Apr 07, 2023	SELL	$39.39 - $51.28 $124,905 - $162,608	-3,171 Reduced 12.37%	22,463 $916,000
Q4 2022 Jan 25, 2023	SELL	$41.75 - $54.5 $248,120 - $323,893	-5,943 Reduced 18.82%	25,634 $0
Q3 2022 Oct 13, 2022	SELL	$43.76 - $53.42 $720,508 - $879,560	-16,465 Reduced 34.27%	31,577 $1.38 Million
Q2 2022 Jul 11, 2022	SELL	$46.53 - $55.17 $5.26 Million - $6.23 Million	-112,950 Reduced 70.16%	48,042 $2.52 Million
Q1 2022 May 20, 2022	SELL	$45.75 - $56.69 $793,030 - $982,664	-17,334 Reduced 9.72%	160,992 $8.34 Million
Q4 2021 Feb 15, 2022	SELL	$41.32 - $61.25 $133,174 - $197,408	-3,223 Reduced 1.78%	178,326 $10.5 Million
Q3 2021 Oct 13, 2021	SELL	$39.25 - $50.42 $25,512 - $32,773	-650 Reduced 0.36%	181,549 $7.81 Million
Q2 2021 Jul 14, 2021	BUY	$35.91 - $40.68 $87,799 - $99,462	2,445 Added 1.36%	182,199 $7.14 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $218,555 - $246,487	6,526 Added 3.77%	179,754 $6.51 Million
Q4 2020 Jan 14, 2021	SELL	$33.47 - $42.56 $2,677 - $3,404	-80 Reduced 0.05%	173,228 $6.38 Million
Q3 2020 Oct 13, 2020	BUY	$31.75 - $37.25 $483,806 - $567,615	15,238 Added 9.64%	173,308 $6.36 Million
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $3.27 Million - $3.96 Million	108,456 Added 218.6%	158,070 $5.17 Million
Q1 2020 Apr 09, 2020	BUY	$27.03 - $38.62 $35,030 - $50,051	1,296 Added 2.68%	49,614 $1.62 Million
Q4 2019 Jan 09, 2020	BUY	$32.92 - $37.36 $20,838 - $23,648	633 Added 1.33%	48,318 $1.89 Million
Q3 2019 Oct 11, 2019	BUY	$32.49 - $42.13 $19,494 - $25,278	600 Added 1.27%	47,685 $1.71 Million
Q2 2019 Aug 15, 2019	SELL	$36.98 - $41.52 $119,260 - $133,902	-3,225 Reduced 6.41%	47,085 $2.04 Million
Q1 2019 Apr 09, 2019	SELL	$37.5 - $41.2 $141,562 - $155,530	-3,775 Reduced 6.98%	50,310 $2.14 Million
Q4 2018 Jan 14, 2019	SELL	$38.47 - $43.86 $75,978 - $86,623	-1,975 Reduced 3.52%	54,085 $2.36 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $87,036 - $105,570	-2,525 Reduced 4.31%	56,060 $2.47 Million
Q2 2018 Aug 07, 2018	BUY	$32.98 - $35.16 $15,863 - $16,911	481 Added 0.83%	58,585 $2.13 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $9,062 - $10,513	-284 Reduced 0.49%	58,104 $2.06 Million
Q4 2017 Jan 16, 2018	BUY	$33.26 - $35.29 $47,894 - $50,817	1,440 Added 2.53%	58,388 $2.12 Million
Q3 2017 Nov 14, 2017	BUY	$31.0 - $34.15 $1.77 Million - $1.94 Million	56,948	56,948 $2.03 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greylin Investment Mangement Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greylin Investment Mangement Inc with notifications on news.

Account

Greylin Investment Mangement Inc Pfizer Inc Transaction History